CDNA · CareDx, Inc.
$35.75
-0.61 (-1.68%)
At close · Jul 28
Market Cap
$1.85B
Shares
51.66M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$379.81M
+13.8%
FY2025
Net Income
-$21.35M
-140.6%
FY2025
Gross Margin
64.23%
+7.3pp
FY2019
Operating Margin
-8.1%
-20.3pp
FY2025
Diluted EPS
-$0.40
-143%
FY2025
Operating Cash Flow
$42.03M
+10.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2027 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $500M | $412.82M | $379.81MG | $333.79MG | $280.32M | $321.79M | $296.4M | $192.19M | $127.07M | $76.57M | $48.32M | $40.63M | $28.14M | $27.31M | $22.1M | $20.45M | |
| — | — | — | — | — | — | — | — | — | — | — | -$1.86M | -$1.59M | -$2.12M | -$2.15M | -$2.7M | |
| — | $51.63M | — | — | — | — | — | — | $45.46M | $32.99M | $21.37M | $10.24M | $0 | $0 | — | — | |
| — | $98.19M | — | — | — | — | — | — | $81.61M | $43.58M | $26.95M | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | 64.23% | 56.92% | 55.78% | — | — | — | — | — | |
| — | $74.32M | $71.43M | $72.51M | $82.42M | $90.39M | $76.53M | $48.94M | $30.71M | $14.51M | $12.39M | $12.39M | $9.33M | $3.85M | $3.18M | $4.75M | |
| — | $110.03M | $102.64M | $81.98M | $84.06M | $96.03M | $77.25M | $53.86M | $38.89M | $21.67M | $12.81M | $11.17M | $8.35M | $6.47M | $5.89M | $5.42M | |
| — | $115.28M | $107.57M | $125.14M | $118.84M | $100.4M | $74.96M | $48.81M | $36.54M | $22.98M | $20.09M | $20.73M | $12.25M | $8.44M | $4.81M | $4.69M | |
| — | $6.43M | $6.35M | $6.35M | $6.47M | $6.23M | $5.8M | $4.8M | $3.6M | $2.4M | $2.6M | $1.7M | $0 | — | — | — | |
| — | — | $15.02M | $14.19M | $14.39M | $11.6M | $8.8M | $7.01M | $5.52M | $4.22M | $3.73M | $2.92M | $796K | $512K | $663K | $1.07M | |
| — | — | — | $1.78M | $2.32M | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| — | $429.03M | $410.59M | $293.02M | $483.69M | $399.02M | $326.12M | $214.72M | $151.6M | $92.15M | $47.25M | $77.96M | $40.08M | $26.06M | $22.96M | $22.79M | |
| — | -$16.21M | -$30.78M | $40.77M | -$203.36M | -$77.23M | -$29.73M | -$22.53M | -$24.53M | -$15.58M | -$20.29M | -$37.33M | -$11.93M | $1.25M | -$857K | -$2.34M | |
| — | — | -8.1% | 12.21% | -72.55% | -24% | -10.03% | -11.72% | -19.31% | -20.35% | -42% | -91.88% | -42.4% | 4.58% | -3.88% | -11.45% | |
| — | — | -$15.76M | $54.96M | -$188.98M | -$65.64M | -$20.93M | -$15.52M | -$19.01M | -$11.36M | -$16.57M | -$34.41M | -$11.14M | $1.76M | -$194K | -$1.27M | |
| — | $8.2M | $9.7M | $12.09M | $13.22M | $997K | -$2.36M | $2.78M | $585K | -$32.64M | -$36.98M | -$1.92M | -$188K | -$78K | -$536K | -$14K | |
| — | — | $0 | $0 | $2.11M | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| — | -$8.01M | -$21.08M | $52.86M | -$190.14M | -$76.23M | -$32.09M | -$19.75M | -$23.95M | -$48.22M | -$57.27M | -$41.36M | -$13.71M | -$719K | -$3.54M | -$5.06M | |
| — | $180.99K | $271K | $310K | $141K | $379K | -$1.43M | -$1.04M | -$1.98M | -$1.43M | -$1.71M | -$1.61M | $0 | -$1.5M | $0 | $0 | |
| — | -$8.19M | -$21.35M | $52.55M | -$190.28M | -$76.61M | -$30.66M | -$18.71M | -$21.97M | -$46.76M | -$55.47M | -$39.47M | -$13.71M | $781K | -$3.54M | -$5.06M | |
| — | — | -5.62% | 15.74% | -67.88% | -23.81% | -10.34% | -9.74% | -17.29% | -61.06% | -114.79% | -97.14% | -48.7% | 2.86% | -16.03% | -24.74% | |
| — | — | — | — | — | — | — | $0 | $0 | -$25K | -$91K | -$287K | $0 | $0 | — | — | |
| — | -$8.19M | -$21.35M | $52.55M | -$190.28M | -$76.61M | -$30.66M | — | — | — | — | — | — | — | — | — | |
| — | -$7.38M | -$18.3M | $50.94M | -$189.74M | -$79.45M | -$33.24M | -$15.61M | -$22.9M | -$48.69M | -$54.16M | -$43.13M | -$13.71M | $781K | — | — | |
| USD/shares | — | — | -$0.40 | $1.00 | -$3.54 | -$1.44 | -$0.59 | -$0.40 | -$0.52 | -$1.31 | -$2.38 | -$2.39 | -$1.16 | $0.13 | -$3.50 | -$5.01 |
| USD/shares | — | — | -$0.40 | $0.93 | -$3.54 | -$1.44 | -$0.59 | -$0.40 | -$0.52 | -$1.31 | -$2.38 | -$2.39 | -$1.16 | $0.10 | -$3.50 | -$5.01 |
| shares | — | — | 53.29M | 52.77M | 53.76M | 53.32M | 52.24M | 46.48M | 42.15M | 35.64M | 23.33M | 16.5M | 11.86M | 5.82M | 1.01M | 1.01M |
| shares | — | — | 53.29M | 56.62M | 53.76M | 53.32M | 52.24M | 46.48M | 42.15M | 35.64M | 23.33M | 16.5M | 11.86M | 9.28M | 1.01M | 1.01M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2025: $116.47M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 3.98×
EV/EBIT
—
P/E (TTM)
—
Peer median 51.53×
Peer medians compare against the 20 similar-size Diagnostics & Research companies (of 48 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Reportable Segment | $379,805,000 | $333,785,000 | $280,324,000 | $321,793,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $359,939,000 | $317,732,000 | $265,630,000 | $307,543,000 | $282,009,000 | $181,503,000 | $116,196,000 | $66,063,000 |
| Non Us | $19,866,000 | $16,053,000 | $14,694,000 | — | — | — | — | — |
| Rest of World | — | — | — | $4,701,000 | $4,566,000 | $3,129,000 | $3,082,000 | $2,904,000 |
| Europe | — | — | — | $9,549,000 | $9,822,000 | $7,562,000 | $7,790,000 | $7,602,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Service | $274,495,000 | $249,381,000 | $209,685,000 | $263,748,000 | $259,285,000 | $163,610,000 | $104,550,000 | $60,300,000 |
| Patient and Digital Solutions | $56,933,000 | $43,621,000 | $37,122,000 | $28,794,000 | $10,280,000 | $9,282,000 | $4,239,000 | — |
| Product | $48,377,000 | $40,783,000 | $33,517,000 | $29,251,000 | $26,832,000 | $19,302,000 | $18,279,000 | $15,674,000 |
| Digital and Other | — | — | — | — | — | — | — | $595,000 |
| License and Other | — | — | — | — | — | — | — | $595,000 |
Key facts
CIK
1217234
CUSIP
14167L103
13F (30d)
28 filings
28 filers
Visit website
Investor relations